Clinical trial

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

NCT04045717

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2020-04-10

PhasePHASE2

Study timeline

Study start (actual)2020-04-10Date precision: day

Registry last updated2023-12-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Adenocarcinomaunresolved

Prostate Cancerunresolved

Prostate Neoplasmunresolved

Interventions

Hypo-FLAME 2.0 studyRADIATION

Sponsors & collaborators

Universitaire Ziekenhuizen KU Leuvenlead sponsor

The Netherlands Cancer Institutecollaborator

Radboud University Medical Centercollaborator

Kom Op Tegen Kankercollaborator

Mapped research locations

LeuvenBelgium1 AmsterdamNetherlands1 NijmegenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04045717 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.